Evaluation of aztreonam in the treatment of severe bacterial infections

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  1985-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/AAC.28.2.222PMID 3834832PMCID PMC180223
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The cephalosporins.

  1985cited by this paper
• In vitro antimicrobial activity of aztreonam alone and in combination against bacterial isolates from pediatric patients

  1984cited by this paper
• Clinical efficacy of ceftazidime. Treatment of serious infection due to multiresistant Pseudomonas and other gram-negative bacteria.

  1984cited by this paper
• Azthreonam activity against gram-negative bacilli.

  1984cited by this paper
• Effect of aztreonam on throat and stool flora of cancer patients

  1984cited by this paper
• Pharmacology of aztreonam after intravenous infusion

  1983cited by this paper
• Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction

  1983cited by this paper
• Binding of monobactams to penicillin-binding proteins of Escherichia coli and Staphylococcus aureus: relation to antibacterial activity

  1983cited by this paper
• Evaluation of lamoxactam in the treatment of severe bacterial infections.

  1983cited by this paper
• Metabolism and pharmacokinetics of aztreonam in healthy subjects

  1983cited by this paper
• Interaction of azthreonam and related monobactams with beta-lactamases from gram-negative bacteria

  1982cited by this paper
• Monobactams—monocyclic β -lactam antibiotics produced by bacteria

  1981cited by this paper
• SQ 26,776: in-vitro antibacterial activity and susceptibility to beta-lactamases.

  1981cited by this paper
• Antibacterial activity of a monocyclic beta-lactam SQ 26,776.

  1981cited by this paper
• Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic.

  1981cited by this paper
• Moxalactam therapy for bacterial infections.

  1981cited by this paper
• Monobactams--monocyclic beta-lactam antibiotics produced by bacteria.

  1981cited by this paper
• Pharmacokinetics of the monobactam SQ 26,776 after single intravenous doses in healthy subjects.

  1981cited by this paper
• In-vivo properties of SQ 26,776.

  1981cited by this paper
• In-vitro activity of the monobactam, SQ 26,776, against Gram-negative bacteria and its stability to their beta-lactamases.

  1981cited by this paper
• Antibacterial activity of a monocyclic β-lactam SQ 26,776

  1981cited by this paper
• Parenteral toxicological profile of the monocyclic beta-lactam antibiotic SQ 26,776 in mice, rats and dogs.

  1981cited by this paper
• Piperacillin therapy for serious bacterial infections.

  1980cited by this paper
• The cephalosporins.

  1977cited by this paper
• Gram-negative rod bacteremia: microbiologic, immunologic, and therapeutic considerations.

  1977cited by this paper
• Results of a Clinical Trial of Cefoxitin, a New Cephamycin Antibiotic

  1977cited by this paper
• Controlled comparison of amikacin and gentamicin.

  1977cited by this paper
• Antibiotic sensitivity testing. Report of an international collaborative study.

  1971cited by this paper
• Relation between dose and levels of gentamicin in blood.

  1971cited by this paper
• Manual of Clinical Microbiology

  1970cited by this paper
• Gram-negative bacteremia.

  1969cited by this paper
• Gram-negative rod bacteremia.

  1969cited by this paper
• Urine osmolality. A definitive test of renal function.

  1962cited by this paper

• ALTERNATIVAS TERAPÊUTICAS PARA O TRATAMENTO DE INFECÇÕES POR Pseudomonas aeruginosa MULTIRRESISTENTES ENDÊMICAS NO BRASIL

  2012cites this paper
• Duration of post-surgical antibiotics in chronic osteomyelitis: empiric or evidence-based?

  2010cites this paper
• Characterization of a Fish Antimicrobial Peptide: Gene Expression, Subcellular Localization, and Spectrum of Activity

  2000cites this paper
• Candida pericarditis: clinical profile and treatment.

  1997cites this paper
• Development of Resistance During Antimicrobial Therapy: A Review of Antibiotic Classes and Patient Characteristics in 173 Studies

  1995cites this paper
• The life and times of the Enterococcus

  1990cites this paper
• Aztreonam activity, pharmacology, and clinical uses.

  1990cites this paper
• Drug therapy. Beta-lactam antibiotics (2).

  1988cites this paper
• Aztreonam: review of the clinical experience and potential uses in pediatrics

  1988cites this paper
• Aztreonam: the first monobactam.

  1988cites this paper
• Aztreonam: critical evaluation of the first monobactam antibiotic in treatment of urinary tract infections.

  1988cites this paper
• Beta-Lactam Antibiotics

  1988cites this paper
• Aminoglycoside antibiotics in infectious diseases. An overview.

  1986cites this paper
• Aztreonam treatment of gram-negative septicemia

  1986cites this paper
• Aztreonam in the treatment of severe urinary tract infections in pediatric patients

  1986cites this paper